4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-23-022695
Director sold 15,295 shares at $9.12 ($139,490)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vance Terry Director | 2023-12-13 | Sale | −15,295 | $9.12 | $139,490 | 5,800 | D: show line 1 in the form |
| Open-market sales · 15,295 sh · avg $9.12 · $139,490 | |||||||
Loading xslF345X05/form4.xml…